Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-site, Interventional, Comparative, Single-arm Trial to Evaluate the Safety and Effectiveness of Keeogo™ Dermoskeleton in Subjects With Hemiparesis Due to Ischemic or Hemorrhagic Stroke.

NCT03986320 is registered in ClinicalTrials.gov with B-Temia, Inc. as lead sponsor.

NCT NCT03986320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03986320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-site, Interventional, Comparative, Single-arm Trial to Evaluate the Safety and Effectiveness of Keeogo™ Dermoskeleton in Subjects With Hemiparesis Due to Ischemic or Hemorrhagic Stroke.
Lead sponsor
B-Temia, Inc.
Phase
Not applicable
Overall status
Completed
Start date
July 22, 2019
Completion date
September 10, 2020
Enrollment
60 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral vascular accident, hemiparesis, stroke, stroke hemorrhagic, stroke, ischemic